University of Kentucky Libraries will host a panel discussion titled, "Generation Open: Researchers' Roles in the Age of Openness," as one of the events presented to celebrate Open Access Week.

UK faculty, students, and postdoctoral fellows recently represented the institution at the second annual SEC Symposium, a program aimed to address significant scholarly issues by bringing together multidisciplinary expertise from across SEC institutions while expanding opportunities for collaboration.

A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4, a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed.

The University of Kentucky College of Public Health has named Nancy Schoenberg as associate dean for research. She currently serves as a standing NIH study section member and as co-director of the Community Engagement and Research Core of the UK Center for Clinical and Translational Science.

Find out how you can participate in research during the University of Kentucky's next #AskACat Twitter chat.

President Eli Capilouto accepted the Ice Bucket Challenge and was joined by faculty and staff that represent the University of Kentucky’s ALS Research Center for the big blue ice bath.

The project will focus on policies related to the built environment (such as sidewalks), overall community design, and shared use of schools (after school hours) to increase access to safe space for physical activity.

Researchers at UK are using magnetic resonance imaging (MRI) technology to better understand the cause of heart failure in patients who received corrective surgery as infants, with the goal of eventually developing new therapies to reduce mortality.

Kentucky is ranked third in the U.S. for incidence of depression, with 23.5 percent of adults experiencing depression at some point during their lives, compared to 18 percent nationally.

A new, lifesaving product aimed at reducing the death toll from heroin abuse is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.